Constellation: MorphoSys cuts R&D from Constellation deal to focus on clinical-stage cancer drugs

Press Release: Constellation : MorphoSys AG Reports Second Quarter and First Half 2021 Results

Constellation: Constellation Pharmaceuticals : Completion of Acquisition or Disposition of Assets (Form 8-K)

Constellation: MorphoSys : to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology (Form 6-K)

Constellation: MorphoSys : Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals (Form 6-K)

Constellation: MorphoSys : Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals (Form 6-K)

Constellation Pharmaceuticals Inc: Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib

Constellation Pharmaceuticals Inc: PRESS RELEASE: Willkie Farr & Gallagher LLP: MorphoSys to acquire Constellation Pharmaceuticals

Constellation Pharmaceuticals Inc: SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Constellation Pharmaceuticals, Inc. - CNST

Constellation Pharmaceuticals Inc: SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Constellation Pharmaceuticals, Inc. - CNST